MX2013007675A - Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa. - Google Patents

Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa.

Info

Publication number
MX2013007675A
MX2013007675A MX2013007675A MX2013007675A MX2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A MX 2013007675 A MX2013007675 A MX 2013007675A
Authority
MX
Mexico
Prior art keywords
human milk
milk oligosaccharides
probiotic
promote growth
beneficial microbiota
Prior art date
Application number
MX2013007675A
Other languages
English (en)
Other versions
MX356184B (es
Inventor
Jomay Chow
Rachael Buck
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2013007675A publication Critical patent/MX2013007675A/es
Publication of MX356184B publication Critical patent/MX356184B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Abstract

Se describen las composiciones nutricionales que incluyen los oligosacáridos de leche humana que se pueden administrar a los individuos, que incluyen bebés prematuros, bebés, infantes y niños, para mejorar la función y la tolerancia gastrointestinales, así como el crecimiento de la microbiota beneficiosa. También se describen los métodos adicionales convenientes para usar las composiciones nutricionales que incluyen los oligosacáridos de leche humana.
MX2013007675A 2010-12-31 2011-12-22 Fórmulación pediátrica sintética que comprende un probiótico. MX356184B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428869P 2010-12-31 2010-12-31
PCT/US2011/067012 WO2012092155A1 (en) 2010-12-31 2011-12-22 Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota

Publications (2)

Publication Number Publication Date
MX2013007675A true MX2013007675A (es) 2013-07-29
MX356184B MX356184B (es) 2018-05-17

Family

ID=45529204

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007675A MX356184B (es) 2010-12-31 2011-12-22 Fórmulación pediátrica sintética que comprende un probiótico.

Country Status (11)

Country Link
US (1) US20120171166A1 (es)
EP (2) EP2658402A1 (es)
CN (1) CN103763940B (es)
BR (1) BR112013016914A2 (es)
CA (1) CA2822660C (es)
HK (1) HK1256876A1 (es)
MX (1) MX356184B (es)
NZ (1) NZ612386A (es)
SG (1) SG191798A1 (es)
TW (1) TW201304692A (es)
WO (1) WO2012092155A1 (es)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2558112T3 (es) 2010-12-29 2016-02-02 Abbott Laboratories Productos nutricionales que incluyen un nuevo sistema lipídico que incluye monoglicéridos
SG191393A1 (en) * 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
SG191394A1 (en) 2010-12-31 2013-08-30 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
US9539269B2 (en) 2010-12-31 2017-01-10 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
US20140371173A1 (en) * 2011-02-10 2014-12-18 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
EP2750523A1 (en) * 2011-08-29 2014-07-09 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
ES2795665T3 (es) * 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2745705A1 (en) * 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
CA2897363C (en) * 2013-01-21 2016-06-21 Universitat Zurich Baby food composition comprising viable propionic acid-producing bacteria
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
NZ711956A (en) 2013-03-08 2018-06-29 Axiom Foods Inc Rice protein supplements
WO2014200334A1 (en) * 2013-06-14 2014-12-18 N.V. Nutricia Synbiotic composition for treatment of infections in allergic patients
MX2016007715A (es) * 2013-12-19 2016-09-07 Nestec Sa Composicion nutricional para reducir el estres metabolico en infantes.
SG11201608248YA (en) 2014-04-08 2016-10-28 Abbott Lab Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
CN107249611A (zh) 2014-10-24 2017-10-13 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20170258820A1 (en) * 2014-10-29 2017-09-14 Glycom A/S Synthetic composition and method for promoting mucosal healing
CN107073021A (zh) 2014-10-29 2017-08-18 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
CN107106584A (zh) * 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
CN104528149A (zh) * 2014-12-31 2015-04-22 福建美力生生物科技股份有限公司 一种即用型益生菌饮料产品
ES2952585T3 (es) * 2015-01-14 2023-11-02 Infant Bacterial Therapeutics Ab Preparado de lactobacillus reuteri y citrato para uso médico
EP3264920B1 (en) * 2015-03-05 2020-12-16 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
RU2724590C2 (ru) * 2015-08-04 2020-06-25 Сосьете Де Продюи Нестле С.А. Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании
US20180220691A1 (en) * 2015-08-04 2018-08-09 Nestec S.A. Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
PL3349763T3 (pl) * 2015-09-14 2022-01-03 Glycom A/S Kompozycja do zastosowania w modulowaniu mikrobioty
US10780103B2 (en) * 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
CN108495560A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 用于预防和/或治疗皮肤病症和皮肤疾病的组合物
EP3407895A1 (en) * 2016-01-26 2018-12-05 Nestec S.A. Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
US11229659B2 (en) 2016-01-26 2022-01-25 Societe Des Produits Nestle S.A. Compositions with specific oligosaccharides to prevent or treat allergies
WO2017129640A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
CN108495635A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 人乳低聚糖对抗日后的脂肪量过度积聚和相关的健康障碍
BR112018068261A2 (pt) * 2016-03-11 2019-01-15 Evolve Biosystems Inc microorganismo comensal transitório para melhorar a saúde do intestino
EP3452050B1 (en) * 2016-05-05 2022-11-23 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
EP3458073B1 (en) * 2016-05-19 2023-10-25 Glycom A/S Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
MX2018015725A (es) * 2016-07-01 2019-09-09 Evolve Biosystems Inc Método para facilitar la maduración del sistema inmunitario de mamíferos.
EP3493686B1 (en) * 2016-08-04 2024-03-27 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
US20180064739A1 (en) * 2016-09-06 2018-03-08 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
US20180133287A1 (en) * 2016-11-14 2018-05-17 Mead Johnson Nutrition Company Nutritional compositions providing dietary management of colic
WO2018118558A1 (en) * 2016-12-19 2018-06-28 Aly Hany Z Medical-grade honey for growth enhancement of infants
US11253530B2 (en) 2017-05-09 2022-02-22 Societe Des Produits Nestle S.A. Synergistic production of butyrate associated with the complexity of HMOS blend for use in infants or young children for health purposes
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
EP3629768A1 (en) 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
US11541069B2 (en) * 2017-11-02 2023-01-03 Glycom A/S One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
WO2019106618A1 (en) * 2017-11-30 2019-06-06 Glycom A/S Mixture of hmos for treating wheat sensitivity
MX2020007192A (es) * 2017-12-01 2020-08-24 Nestle Sa Composicion fortificadora de leche humana.
JP2021505171A (ja) * 2017-12-08 2021-02-18 イェンネワイン バイオテクノロジー ゲーエムベーハーＪｅｎｎｅｗｅｉｎ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ ＧｍｂＨ 噴霧乾燥シアリルラクトース
CN111479573A (zh) * 2017-12-21 2020-07-31 雀巢产品有限公司 用于促进肠道肌肉生长和发育以及相关联的肠道能动性的组合物
CN111935995A (zh) * 2018-03-29 2020-11-13 森永乳业株式会社 营养组合物以及使用了该营养组合物的饮食品组合物和配方奶粉
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
EP3583858A1 (en) * 2018-06-20 2019-12-25 DuPont Nutrition Biosciences ApS Compositions for treating or preventing gut barrier dysfunction
SG11202011820VA (en) * 2018-05-30 2020-12-30 Evolve Biosystems Inc Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
WO2019232513A1 (en) * 2018-06-01 2019-12-05 Evolve Biosystems, Inc. Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
BR112020023102A2 (pt) * 2018-06-25 2021-02-02 Société des Produits Nestlé S.A. uso de oligossacarídeos de leite humano, e composição que compreende os mesmos
EP3820307A1 (en) 2018-07-12 2021-05-19 N.V. Nutricia Nutritional composition for improving intestinal barrier integrity, preparation of the composition and method of treatment
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
US20220287349A1 (en) * 2018-12-21 2022-09-15 Societe Des Produits Nestle S.A. A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function
JP2022523560A (ja) * 2019-03-05 2022-04-25 グリコム・アクティーゼルスカブ 実行機能の向上に用いるためのヒトミルクオリゴ糖
CN113518622A (zh) * 2019-03-05 2021-10-19 雀巢产品有限公司 用于增强执行功能的营养组合物
KR20220017988A (ko) * 2019-06-05 2022-02-14 글리콤 에이/에스 비-셀리악 밀 및/또는 글루텐 민감성을 앓고 있는 환자에서 증상 치료에 사용하기 위한 모유 올리고사카라이드
JP2023502260A (ja) * 2019-11-20 2023-01-23 アボット・ラボラトリーズ クロストリジウム・ディフィシル感染症を治療する栄養組成物
CN112869168B (zh) * 2019-11-29 2023-06-06 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
AU2020419435A1 (en) * 2019-12-30 2022-05-26 Société des Produits Nestlé S.A. Infant formula
JP7474596B2 (ja) 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
JP2021112165A (ja) * 2020-01-20 2021-08-05 森永乳業株式会社 組成物並びに飲食品組成物、栄養組成物および調製乳
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
EP4243634A1 (en) * 2020-11-10 2023-09-20 Société des Produits Nestlé S.A. Nutritional composition
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
WO2022117538A1 (en) * 2020-12-01 2022-06-09 Frieslandcampina Nederland B.V. 2'-fucosyllactose for use in stimulating f. prausnitzii abundance
CA3204530A1 (en) * 2021-01-12 2022-07-21 Gregory Mckenzie Synbiotic treatment regimens
CN113796546A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 改善肠道屏障功能母乳低聚糖组合物及其应用
CN114223728B (zh) * 2021-11-30 2024-03-26 内蒙古伊利实业集团股份有限公司 含有益生元与益生菌的早产/低出生体重婴儿配方奶粉

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK112399A3 (en) 1997-02-21 2000-12-11 Abbott Lab Methods and compositions for reducing the incidence of necrotizing enterocolitis
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
CN1229115C (zh) * 2000-02-17 2005-11-30 惠氏公司 含有益生素物质的营养配方
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
CN101432007A (zh) * 2006-03-07 2009-05-13 雀巢产品技术援助有限公司 合益素混合物
CA2883256A1 (en) * 2006-03-10 2007-09-20 N.V. Nutricia Use of non-digestible saccharides for strengthening the immune system
US20070255598A1 (en) * 2006-03-29 2007-11-01 Mccarthy Nancy J Compliance aid, kits comprising the compliance aid, and methods of use
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009102193A1 (en) * 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
EP2127661A1 (en) * 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
WO2010023178A1 (en) * 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
ES2569241T5 (es) * 2010-01-19 2019-09-11 Abbott Lab Una composición que comprende Lactobacillus rhamnosus HN001 y prebióticos para su uso en el tratamiento de la enfermedad pulmonar alérgica

Also Published As

Publication number Publication date
CN103763940B (zh) 2015-10-14
TW201304692A (zh) 2013-02-01
CN103763940A (zh) 2014-04-30
EP3335577A1 (en) 2018-06-20
EP2658402A1 (en) 2013-11-06
US20120171166A1 (en) 2012-07-05
BR112013016914A2 (pt) 2019-09-24
MX356184B (es) 2018-05-17
CA2822660A1 (en) 2012-07-05
SG191798A1 (en) 2013-08-30
WO2012092155A1 (en) 2012-07-05
CA2822660C (en) 2021-09-07
HK1256876A1 (zh) 2019-10-04
NZ612386A (en) 2015-02-27

Similar Documents

Publication Publication Date Title
MX2013007675A (es) Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa.
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MX2021014138A (es) Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
MY174541A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX2020010780A (es) Métodos para disminuir la incidencia de la enterocolitis necrotizante en bebés, infantes, o niños al usar los oligosacáridos de leche humana.
MY173726A (en) Synbiotics combination for brain improvement
MY186188A (en) Nutritional phytonutrient compositions
MX350782B (es) Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
MX352040B (es) Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
SG178991A1 (en) Anti-gitr antibodies
MY175195A (en) Nutritional compositions
PH12017500873A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
Boon-yasidhi et al. Adverse effects of risperidone in children with autism spectrum disorders in a naturalistic clinical setting

Legal Events

Date Code Title Description
FG Grant or registration